Establishing reference intervals for von Willebrand factor multimers

Establishing reference intervals for von Willebrand factor multimers

Background: von Willebrand factor (VWF) multimers (VWF:MM) methodologies are technically difficult, laborious, time consuming, non-standardized and results vary between laboratories. A new semi automated VWF:MM assay is available for routine use (Sebia). Due to lack of reference values for VWF:MM fr...

Full description

Bibliographic Details
Main Authors:	Pikta Marika, Vasse Marc, Smock Kristi J., Moser Karen A., van Dievoet Marie-Astrid, Lejniece Sandra, Szanto Timea, Bautista Hector, Nouadje George, Banys Valdas
Format:	Article
Language:	English
Published:	Society of Medical Biochemists of Serbia, Belgrade 2022-01-01
Series:	Journal of Medical Biochemistry
Subjects:	von willebrand factor von willebrand factor multimers quantitative analysis reference intervals
Online Access:	https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2022/1452-82582201115P.pdf

Similar Items

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021-11-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
by: Inge Vangenechten, et al.
Published: (2020-08-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

Analysis of von Willebrand Disease in the “Heart of Europe”
by: Inge Vangenechten, et al.
Published: (2022-10-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
by: Marcela Montilla, et al.
Published: (2022-11-01)

Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease
by: Muhammad Asif Naveed, et al.
Published: (2022-05-01)

Diagnosis of von Willebrand disease during the management of deep neck abscess: A case report
by: Akihisa Tanaka, et al.
Published: (2022-12-01)

Von Willebrand disease : basic and clinical aspects /
by: Federici, Augusto B. 534507
Published: (c201)

Allopurinol-induced acquired von Willebrand syndrome
by: Juan Eirís, et al.
Published: (2023-10-01)

Platelets compensate for poor thrombin generation in type 3 von Willebrand disease
by: Timea Szanto, et al.
Published: (2020-01-01)

Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms
by: Maurice Swinkels, et al.
Published: (2021-08-01)

Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device
by: Antoine Rauch, et al.
Published: (2019-02-01)

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
by: Martin Büchsel, et al.
Published: (2023-01-01)

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu
by: Ahmet Arslan, et al.
Published: (2011-11-01)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow
by: Hiroaki Yaoi, et al.
Published: (2023-12-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
by: Marie‐Daniéla Dubois, et al.
Published: (2022-05-01)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
by: Alessandra Casonato, et al.
Published: (2021-08-01)

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure
by: Pamela A. Christopherson, et al.
Published: (2022-10-01)

Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH)
by: Ivonne Wieland, et al.
Published: (2022-11-01)

Differential diagnosis of neonatal alloimmune thrombocytopenia: Type 2B von Willebrand disease
by: Mathilde Penel-Page, et al.
Published: (2017-11-01)

Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer
by: Isabell Pekrul, et al.
Published: (2019-02-01)

Frequency Assessment of the H817Q (2451T→A) Variant of von Willebrand Gene in Individuals without Hemorrhagic Signs
by: Mansoureh Bakhtiari, et al.
Published: (2016-08-01)

Commonly used anti–von Willebrand factor antibody for multimer analysis cross‐reacts with fibronectin, which is difficult to distinguish from von Willebrand factor
by: Yuka Eura, et al.
Published: (2021-08-01)

Von willebrand factor level and activity in correlation with D-dimer level among COVID-19 patients in Saudi Arabia
by: Rehab Yusuf Al-Ansari, et al.
Published: (2022-01-01)

Von Willebrand Factor Multimers and the Relaxation Response: A One-Year Study
by: Carlo Dal Lin, et al.
Published: (2021-04-01)

Shear-induced acquired von Willebrand syndrome: an accomplice of bleeding events in adults on extracorporeal membrane oxygenation support
by: Haiwang Wang, et al.
Published: (2023-07-01)

The von Willebrand factor as a marker of partially controlled asthma severity in children
by: N.I. Makieieva, et al.
Published: (2023-09-01)

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu
by: Ahmet Arslan, et al.
Published: (2011-11-01)

Determining the relationship between "microvessel density" and different grades of astrocytoma based on immunohistochemistry for "factor VIII-related antigen" (von Willebrand factor) expression in tumor microvessels
by: Mahzouni Parvin, et al.
Published: (2010-10-01)

Clinicopathological Profile of the von Willebrand Disease in a Tertiary Care Centre in Varanasi
by: Pawan K. Pandey, et al.
Published: (2022-03-01)

Von Willebrand factor and gastric cancer – is there an association? – A pilot study from South India
by: Karthikeyan S, et al.
Published: (2024-03-01)

Role of von Willebrand factor in venous thromboembolic disease
by: Alison Michels, MD, PhD, et al.
Published: (2022-01-01)

Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty
by: Jun Kit He, et al.
Published: (2022-10-01)

بررسی درصد فراوانی بیماری von Willebrand در زنان با خونریزی شدید قاعدگی
by: Fariborz Mokarian, et al.
Published: (2018-10-01)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
by: Benjamin Reardon, et al.
Published: (2021-09-01)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
by: Bauer A, et al.
Published: (2023-06-01)